| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States
|
Santoni, Matteo
|
|
|
19 |
2 |
p. e84-e91
|
article
|
| 2 |
Clinical Considerations and Prognosis of Well-Differentiated Neuroendocrine Tumor Occurring Within a Renal Teratoma—A Case Series
|
Ungerer, Garrett
|
|
|
19 |
2 |
p. e72-e77
|
article
|
| 3 |
Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms
|
Yi, Zhenglin
|
|
|
19 |
2 |
p. 155-161
|
article
|
| 4 |
COVID-19 in Patients With Renal Cell Carcinoma in the Russian Federation
|
Tsimafeyeu, Ilya
|
|
|
19 |
2 |
p. e69-e71
|
article
|
| 5 |
Editorial Board
|
|
|
|
19 |
2 |
p. A1
|
article
|
| 6 |
Impact of COVID-19 Pandemic on Health-Related Quality of Life in Uro-oncologic Patients: What Should We Wait For?
|
Greco, Francesco
|
|
|
19 |
2 |
p. e63-e68
|
article
|
| 7 |
Improving the Stratification of Patients With Intermediate-risk Prostate Cancer
|
Stolzenbach, Lara Franziska
|
|
|
19 |
2 |
p. e120-e128
|
article
|
| 8 |
Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab
|
Fujiwara, Ryo
|
|
|
19 |
2 |
p. e78-e83
|
article
|
| 9 |
Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model
|
Hird, Amanda E.
|
|
|
19 |
2 |
p. e135-e147
|
article
|
| 10 |
Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
|
Marconi, Lorenzo
|
|
|
19 |
2 |
p. e92-e99
|
article
|
| 11 |
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program
|
Diamantopoulos, Leonidas N.
|
|
|
19 |
2 |
p. 144-154
|
article
|
| 12 |
Safety, Efficacy, and Impact on Quality of Life of Palliative Robotic Cystectomy for Advanced Prostate Cancer
|
Bhanvadia, Raj R.
|
|
|
19 |
2 |
p. e129-e134
|
article
|
| 13 |
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer
|
Di Gianfrancesco, Luca
|
|
|
19 |
2 |
p. e100-e119
|
article
|
| 14 |
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients
|
Wenzel, Mike
|
|
|
19 |
2 |
p. 135-143
|
article
|
| 15 |
Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience
|
Hoffman-Censits, Jean
|
|
|
19 |
2 |
p. 176-181
|
article
|
| 16 |
Stage and Grade Migration in Prostate Cancer Treated With Radical Prostatectomy in a Large German Multicenter Cohort
|
Boehm, Katharina
|
|
|
19 |
2 |
p. 162-166.e1
|
article
|
| 17 |
Summary from the Kidney Cancer Association’s Inaugural Think Thank: Coalition for a Cure
|
Rini, Brian
|
|
|
19 |
2 |
p. 167-175
|
article
|
| 18 |
Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti–PD-1/PD-L1 Therapy
|
Carril-Ajuria, Lucia
|
|
|
19 |
2 |
p. 95-102
|
article
|
| 19 |
Systemic Therapies for the Management of Non–Clear Cell Renal Cell Carcinoma: What Works, What Doesn’t, and What the Future Holds
|
Zoumpourlis, Panagiotis
|
|
|
19 |
2 |
p. 103-116
|
article
|
| 20 |
Table of contents
|
|
|
|
19 |
2 |
p. A3-A6
|
article
|
| 21 |
The 2021 Variant Histology Issue
|
Hsieh, James J.
|
|
|
19 |
2 |
p. 93-94
|
article
|
| 22 |
Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens
|
Do, Olivia A.
|
|
|
19 |
2 |
p. 125-134
|
article
|
| 23 |
Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma
|
Deuker, Marina
|
|
|
19 |
2 |
p. 117-124
|
article
|
Journal description